Order Article Reprints

Huntington KE, Louie AD, Srinivasan PR, Schorl C, Lu S, Silverberg D, Newhouse D, Wu Z, Zhou L, Borden BA, et al. GSK-3 Inhibitor Elraglusib Enhances Tumor-Infiltrating Immune Cell Activation in Tumor Biopsies and Synergizes with Anti-PD-L1 in a Murine Model of Colorectal Cancer. International Journal of Molecular Sciences. 2023; 24(13):10870. https://doi.org/10.3390/ijms241310870

Huntington, Kelsey E., Anna D. Louie, Praveen R. Srinivasan, Christoph Schorl, Shaolei Lu, David Silverberg, Daniel Newhouse, Zhijin Wu, Lanlan Zhou, Brittany A. Borden, and et al. 2023. "GSK-3 Inhibitor Elraglusib Enhances Tumor-Infiltrating Immune Cell Activation in Tumor Biopsies and Synergizes with Anti-PD-L1 in a Murine Model of Colorectal Cancer" International Journal of Molecular Sciences 24, no. 13: 10870. https://doi.org/10.3390/ijms241310870

Huntington, K. E., Louie, A. D., Srinivasan, P. R., Schorl, C., Lu, S., Silverberg, D., Newhouse, D., Wu, Z., Zhou, L., Borden, B. A., Giles, F. J., Dooner, M., Carneiro, B. A., & El-Deiry, W. S. (2023). GSK-3 Inhibitor Elraglusib Enhances Tumor-Infiltrating Immune Cell Activation in Tumor Biopsies and Synergizes with Anti-PD-L1 in a Murine Model of Colorectal Cancer. International Journal of Molecular Sciences, 24(13), 10870. https://doi.org/10.3390/ijms241310870